Cargando…

Global responses to oxytetracycline treatment in tetracycline-resistant Escherichia coli

We characterized the global transcriptome of Escherichia coli MG1655:: tetA grown in the presence of ½ MIC (14 mg/L) of OTC, and for comparison WT MG1655 strain grown with 1//2 MIC of OTC (0.25 mg/L OTC). 1646 genes changed expression significantly (FDR > 0.05) in the resistant strain, the majori...

Descripción completa

Detalles Bibliográficos
Autores principales: Møller, Thea S. B., Liu, Gang, Hartman, Hassan B., Rau, Martin H., Mortensen, Sisse, Thamsborg, Kristian, Johansen, Andreas E., Sommer, Morten O. A., Guardabassi, Luca, Poolman, Mark G., Olsen, John E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242477/
https://www.ncbi.nlm.nih.gov/pubmed/32439837
http://dx.doi.org/10.1038/s41598-020-64995-1
_version_ 1783537249829257216
author Møller, Thea S. B.
Liu, Gang
Hartman, Hassan B.
Rau, Martin H.
Mortensen, Sisse
Thamsborg, Kristian
Johansen, Andreas E.
Sommer, Morten O. A.
Guardabassi, Luca
Poolman, Mark G.
Olsen, John E.
author_facet Møller, Thea S. B.
Liu, Gang
Hartman, Hassan B.
Rau, Martin H.
Mortensen, Sisse
Thamsborg, Kristian
Johansen, Andreas E.
Sommer, Morten O. A.
Guardabassi, Luca
Poolman, Mark G.
Olsen, John E.
author_sort Møller, Thea S. B.
collection PubMed
description We characterized the global transcriptome of Escherichia coli MG1655:: tetA grown in the presence of ½ MIC (14 mg/L) of OTC, and for comparison WT MG1655 strain grown with 1//2 MIC of OTC (0.25 mg/L OTC). 1646 genes changed expression significantly (FDR > 0.05) in the resistant strain, the majority of which (1246) were also regulated in WT strain. Genes involved in purine synthesis and ribosome structure and function were top-enriched among up-regulated genes, and anaerobic respiration, nitrate metabolism and aromatic amino acid biosynthesis genes among down-regulated genes. Blocking of the purine-synthesis- did not affect resistance phenotypes (MIC and growth rate with OTC), while blocking of protein synthesis using low concentrations of chloramphenicol or gentamicin, lowered MIC towards OTC. Metabolic-modeling, using a novel model for MG1655 and continuous weighing factor that reflected the degree of up or down regulation of genes encoding a reaction, identified 102 metabolic reactions with significant change in flux in MG1655:: tetA when grown in the presence of OTC compared to growth without OTC. These pathways could not have been predicted by simply analyzing functions of the up and down regulated genes, and thus this work has provided a novel method for identification of reactions which are essential in the adaptation to growth in the presence of antimicrobials.
format Online
Article
Text
id pubmed-7242477
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72424772020-05-30 Global responses to oxytetracycline treatment in tetracycline-resistant Escherichia coli Møller, Thea S. B. Liu, Gang Hartman, Hassan B. Rau, Martin H. Mortensen, Sisse Thamsborg, Kristian Johansen, Andreas E. Sommer, Morten O. A. Guardabassi, Luca Poolman, Mark G. Olsen, John E. Sci Rep Article We characterized the global transcriptome of Escherichia coli MG1655:: tetA grown in the presence of ½ MIC (14 mg/L) of OTC, and for comparison WT MG1655 strain grown with 1//2 MIC of OTC (0.25 mg/L OTC). 1646 genes changed expression significantly (FDR > 0.05) in the resistant strain, the majority of which (1246) were also regulated in WT strain. Genes involved in purine synthesis and ribosome structure and function were top-enriched among up-regulated genes, and anaerobic respiration, nitrate metabolism and aromatic amino acid biosynthesis genes among down-regulated genes. Blocking of the purine-synthesis- did not affect resistance phenotypes (MIC and growth rate with OTC), while blocking of protein synthesis using low concentrations of chloramphenicol or gentamicin, lowered MIC towards OTC. Metabolic-modeling, using a novel model for MG1655 and continuous weighing factor that reflected the degree of up or down regulation of genes encoding a reaction, identified 102 metabolic reactions with significant change in flux in MG1655:: tetA when grown in the presence of OTC compared to growth without OTC. These pathways could not have been predicted by simply analyzing functions of the up and down regulated genes, and thus this work has provided a novel method for identification of reactions which are essential in the adaptation to growth in the presence of antimicrobials. Nature Publishing Group UK 2020-05-21 /pmc/articles/PMC7242477/ /pubmed/32439837 http://dx.doi.org/10.1038/s41598-020-64995-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Møller, Thea S. B.
Liu, Gang
Hartman, Hassan B.
Rau, Martin H.
Mortensen, Sisse
Thamsborg, Kristian
Johansen, Andreas E.
Sommer, Morten O. A.
Guardabassi, Luca
Poolman, Mark G.
Olsen, John E.
Global responses to oxytetracycline treatment in tetracycline-resistant Escherichia coli
title Global responses to oxytetracycline treatment in tetracycline-resistant Escherichia coli
title_full Global responses to oxytetracycline treatment in tetracycline-resistant Escherichia coli
title_fullStr Global responses to oxytetracycline treatment in tetracycline-resistant Escherichia coli
title_full_unstemmed Global responses to oxytetracycline treatment in tetracycline-resistant Escherichia coli
title_short Global responses to oxytetracycline treatment in tetracycline-resistant Escherichia coli
title_sort global responses to oxytetracycline treatment in tetracycline-resistant escherichia coli
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242477/
https://www.ncbi.nlm.nih.gov/pubmed/32439837
http://dx.doi.org/10.1038/s41598-020-64995-1
work_keys_str_mv AT møllertheasb globalresponsestooxytetracyclinetreatmentintetracyclineresistantescherichiacoli
AT liugang globalresponsestooxytetracyclinetreatmentintetracyclineresistantescherichiacoli
AT hartmanhassanb globalresponsestooxytetracyclinetreatmentintetracyclineresistantescherichiacoli
AT raumartinh globalresponsestooxytetracyclinetreatmentintetracyclineresistantescherichiacoli
AT mortensensisse globalresponsestooxytetracyclinetreatmentintetracyclineresistantescherichiacoli
AT thamsborgkristian globalresponsestooxytetracyclinetreatmentintetracyclineresistantescherichiacoli
AT johansenandrease globalresponsestooxytetracyclinetreatmentintetracyclineresistantescherichiacoli
AT sommermortenoa globalresponsestooxytetracyclinetreatmentintetracyclineresistantescherichiacoli
AT guardabassiluca globalresponsestooxytetracyclinetreatmentintetracyclineresistantescherichiacoli
AT poolmanmarkg globalresponsestooxytetracyclinetreatmentintetracyclineresistantescherichiacoli
AT olsenjohne globalresponsestooxytetracyclinetreatmentintetracyclineresistantescherichiacoli